The FTSE 100 is heading for its worst week since mid-April, yet small-cap stocks have navigated the turbulent period with relative calm and resilience. A volatile bond market placed a risk premium
Voice search is emerging as a critical front in legal digital marketing, yet many law firms remain focused elsewhere while potential clients slip away. Annette Choti, Esq., founder and CEO of Law
More
London’s FTSE 100 closed higher on Friday, bucking a broader global trend as technology sector weakness and geopolitical uncertainty weighed on markets elsewhere. The FTSE 100 Index ended the session up 28.13
More
The FTSE 100 index rose on Thursday, buoyed by strong gains across the utilities and energy sectors, lifting the broader market higher. Energy stocks provided meaningful upward momentum, reflecting continued investor appetite
More
CG Life and its 24/364 platform have officially launched the inaugural 24/364 Rare Disease Film Festival, a first-of-its-kind cultural event dedicated to rare disease storytelling. The festival aims to amplify the voices
More
As the 2026 election cycle advances, state attorney general races are emerging as a critical factor in how companies assess their legal and regulatory exposure across the country. Once considered niche political
More
The Department of Justice is drawing renewed criticism over its Biglaw subpoena strategy, with observers widely sceptical the approach will achieve its intended outcome. Legal commentators have suggested the DOJ’s handling of
More
IBM (NYSE: IBM) shares dropped sharply by 25% after the company issued a warning related to its second quarter outlook on AI spending. The significant share price decline reflects growing investor concern
More
Outgoing Prime Minister Sir Keir Starmer collected sport-related freebies worth tens of thousands of pounds during his two years in Downing Street. Official figures declared in the register of accepted gifts and
More
Germany’s sweeping health insurance overhaul is colliding with a US Section 301 trade investigation, creating mounting pressure across global pharmaceutical supply chains. A fixed 15.5% manufacturer rebate on patented branded drugs has
More
A series of recent US Supreme Court decisions has fundamentally shifted how regulatory challenges must be approached, placing threshold questions ahead of traditional administrative review. Businesses have long focused on whether agency
More